1Q2017 法人說明會 Jun. 9, 2017

Similar documents
Growth in core businesses offsets weaker non-interest income. DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM

Summary of Results for the First Half of FY2015/3

Singapore Exchange Limited 1Q FY2009 Financial Results

Hyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011

BANK HANDLOWY W WARSZAWIE S.A. 1Q 2009 consolidated financial results -1-

May 6, 2008 First Quarter 2008 Results

Q Investor Kit JANUARY-JUNE 2013

Q Investor Kit JANUARY-MARCH 2013

BancAnalysts Association of Boston Conference Presentation. November 3, 2017

For personal use only

Q Investor Kit JANUARY-MARCH 2014

Q Investor Kit JANUARY-JUNE 2014

DELICA D:5 ACTIVE GEAR 0

Forward Looking Information

For personal use only

Business Results. for the First Quarter of FY2016/3. August 4, 2015 (Tue.) NH Foods Ltd.

WntResearch. 100% one-week return? 16 October 2017 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE

Q Investor Kit January December 2014

Group financial results for the first quarter 2008

Altria Group Inc. Ticker: MO

Telekom Austria Group Results for the 1st Quarter May 27, 2003

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018

Third-quarter results 2013

Results Briefing. 15 ~ 17 May 2007

Endesa 1Q 2017 Results 09/05/2017

Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, András Tövisi Chairman of the Board of Directors

5.00% CAP Rate $5,865,000. DeerfieldPartners. John Giordani Art Griffith (415) Walgreens Pharmacy #4571 Boston Suburb

Hong Leong Bank Berhad (97141 X) A Member of the Hong Leong Group. A Member of the Hong Leong Group ANNUAL REPORT 2008

METVIX PDT ON THE MARKET IN GERMANY AND UK

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical

Zacks Small-Cap Research

Q2 INVESTOR KIT JANUARY-JUNE 2011

FY2007 Consolidated Financial Overview

FY2009 First Quarter Financial Results. SUZUKI MOTOR CORPORATION August 3, 2009

BALCHEM CORPORATION. Q Investor Relations Presentation

Coloplast A/S. Investor presentation 1H 2005/06

APPLIANCE TELECOMMUNICATIONS

CENTRALE. Monetary. compared. domestic. million.

Altria Group Inc (MO-NYSE)

RAI: Strong key-brands performance delivers 2Q13 profit growth; Company reaffirms full-year EPS guidance

Small-Cap Research. VolitionRx Ltd (VNRX-NYSE) VNRX: More Positive Data in Colon/Lung Cancers. Anticipating Initial Launch This Year OUTLOOK

M e d i a s e t G r o u p

FINANCIAL RESULTS 1H 2015 Core revenues supporting 2015 plan delivery

Welcome to LG Electronics

ASL MARINE. DBS Vickers Pulse of Asia Roadshow 10 January 2012

Small-Cap Research. Celator Pharma (CPXX-NASDAQ)

Q Investor Kit January December 2015

FINANCIAL RESULTS 1H 2016 Growth in key volumes and core revenues

Consolidated: Financial Summary

Boiron Group confirms its forecasts for year 2008 : sales increase and growth in current operating income.

Investor Relations 1Q 2017

ONO PHARMACEUTICAL CO., LTD.

ResMed Inc. 36 th Annual J.P. Morgan Healthcare Conference

RAI reports strong 2Q16 performance and positive outlook; Accelerates returns to shareholders

Investor Presentation. Q April 26, 2018

6.00% CAP Rate $5,600,000. DeerfieldPartners. John Giordani Art Griffith (415) Actual Store

Investor Presentation

Effective Tobacco Tax Reform: Evidence from China

1Q16 FINANCIAL RESULTS

Investor Presentation. Q October 26, 2017

NASDAQ: FHCO 2016 Annual Meeting

A world leader in allergy immunotherapy

Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs

Corporate Presentation October New growth cycle and value innovation

HILLENBRAND INDUSTRIES INC

1Q 2015 Results A Positive Start to 2015

Mount Prospect, Illinois

Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO

ONO PHARMACEUTICAL CO., LTD.

Small-Cap Research. VolitionRx Ltd (VNRX-OTC) VNRX: 938-Sample Set Supports Earlier Findings of High Accuracy in Colon Cancer Detection OUTLOOK

SUMMARY TERM SHEET. Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL )

Letter to Shareholders SEMI-ANNUAL REPORT 2008

Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO

artnet AG Quarterly Interim Statement for the First Quarter of 2016 artnet AG Quarterly Interim Statement for the First Quarter of 2016

Presentation First quarter 2006

Supplementary Data of Consolidated Financial Statements for the third quarter ended December 31, 2016

ARUBA RECENT ECONOMIC DEVELOPMENTS AND OUTLOOK. Presented by Jane R. Semeleer President Centrale Bank van Aruba May 30, 2011

The Dental Corporation Opportunity

QUALITAS MEDICAL GROUP LIMITED. CORPORATE PRESENTATION January 2010

Financial Presentation

Coloplast A/S. Investor Presentation 2005/06

Bank of America 38 th Annual Investment Conference. San Francisco, CA September 17 th, 2008

Walgreens (WAG) Analyst: Juan Fabres Fall 2014

Dainippon Pharmaceutical and Sumitomo Pharmaceuticals Finalize Merger Agreement

THIRD QUARTER REPORT 2011 (UNAUDITED)

Total Face Group Limited

J.P. Morgan. 27 th Annual Healthcare Conference. San Francisco January 14 th, 2009

Presentation of. Burgdorf, 1 st November 2012

WntResearch. Pearls on a string. 3 September 2018 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE

(LO-NYSE) SUMMARY. Risk Level *

Interim Report 1 January September 2017

BiOPTiK TECHNOLOGY, INC. Outlook Dec Listed Number:4161

PhotoCure ASA Presentation First quarter 2005 May 3, 2005

LUZHOU BIO-CHEM TECHNOLOGY LIMITED. 1HFY2006 Results Briefing. August 15, 2006

Zacks Small-Cap Research Sponsored Impartial - Comprehensive

Korean Airlines Q Results

1Q2005. Hera Group presentation

FIRSTQUARTER2018 RESULTSPRESENTATION

Transcription:

1Q2017 法人說明會 Jun. 9, 2017

FE group business Span over 10 major industries Own over 240 companies Established in 1937 9 public listed companies in Taiwan and HK Petrochemical & energy Polyester & synthetic fiber Cement & building material Retail & department store Financial services 7 companies in operation across Taiwan and China Oriental Petrochemical (Taiwan) over 1 million tons annual PTA capacity 21 companies in operation across Taiwan, China and Vietnam Group s polyester capacity over 2 million tons, one of the world's 5 largest manufacturers 27subsidiaries integrating Taiwan and China markets Main operation unit Asia Cement to achieved 40 m tons of annual capacity Total sales surpassed NT$ 120 billion Together owns 50 stores across both sides of Strait 10 companies in operation across 7 financial service fields, in Taiwan and China FEIB is the flagship operating entity Sea/Land transportation Communications and Internet Construction Hotel services Philanthropic organizations 12 subsidiaries in operation Flagship U-Ming Marine Transport has 47 vessels and a shipping capacity of 5.99 million DWT The only one pure mobile operator in Taiwan Invested in FETC, more than 5 million vehicles have installed OBUs and over 1 billion tolls collected. 7 subsidiaries in operation Projects in development such as "Far Eastern Telecom Park" and Yilan Resort Shangri-La's Far Eastern Plaza Hotel Taipei Far Eastern Plaza Hotel Tainan Awarded "The 500 Best Hotels in the World" Established Yuan Ze University Founded Far Eastern memorial Hospital 2

Contents Financial highlights Key strategies 3

Assets CAGR +5.6% (NT$Bn) 361 360 9% 10% 377 10% 418 9% 438 10% 466 9% 492 10% 522 11% 547 15% 561 17% 599 16% +25.8% 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 1Q 2017 Source: Consolidated financial reports 4

Loans Period-end 355 (NT$Bn) 400 324 339 400 361 +6.5% (NT$Bn) 329 355 +7.6% 350 350 55 +3.9% 300 57 300 (%) 57 (%) 250 250 58 56 +4.5% 200 200 150 100 150 43 43 45 100 +9.4% 42 44 +12.6% 50 0 50 2014 2015 0 2016 1Q 2016 1Q 2017 2014 20152014 20162015 2016 Corporate Consumer Corporate Consumer * Corporate banking includes SMEs **Source: Consolidated financial reports 5

Deposits Period-end (NT$Bn) 424 452 453 +0.3% (NT$Bn) 432 488 +13.2% 400 400 350 300 (%) 47 350 47 47 300 +1.3% (%) 49 47 +8.5% 250 250 200 200 150 100 150 53 53 53 100-0.6% 51 53 +17.7% 50 0 50 2014 2015 0 2016 1Q 2016 1Q 2017 2014 20152014 20162015 2016 Corporate Consumer Corporate Consumer * Corporate deposit excludes remittance **Source: Consolidated financial reports 6

Asset quality NPL Ratio NPL Coverage Ratio Loan Coverage Ratio 0.25% 0.23% 0.27% 0.26% 0.27% 0.19% 0.30% 0.25% 555% 531% 511% 503% 501% 726% 556% 453% 1.34% 1.34% 1.30% 1.32% 1.39% 1.41% 1.36% 1.34% 2015 1Q 2016 2016 1Q 2017 2015 1Q 2016 2016 1Q 2017 2015 1Q 2016 2016 1Q 2017 Industry FEIB Source: Consolidated financial reports Industry: 36 Commercial Banks 7

BIS & Liquidity CAR & Tier1* LDR & DDR 12.9% 12.6% 13.1% 13.8% 76.5% 74.9% 76.2% 79.6% 72.6% 9.1% 9.3% 9.5% 10.0% 25.4% 28.5% 28.9% 28.8% 26.1% 2014 2015 2016 1Q 2017 2014 2015 1Q 2016 2016 1Q 2017 CAR Tier 1 LDR DDR *CAR & Tier 1: unconsolidated # Source: Consolidated financial reports 8

Revenue Revenue NII (NT$Bn) -2.5% -4.1% (NT$Bn) -0.3% -8.9% 10.9 11.2 10.9 2.6 2.4 5.4 5.8 5.8 1.5 1.3 2014 2015 2016 1Q 2016 1Q 2017 2014 2015 2016 1Q 2016 1Q 2017 Net fee income Net trading & investment income (NT$Bn) +9.3% -0.5% (NT$Bn) -0.4% +56.8% 2.9 3.1 3.4 0.8 0.8 1.7 1.4 1.4 0.3 0.5 2014 2015 2016 1Q 2016 1Q 2017 2014 2015 2016 1Q 2016 1Q 2017 Source: Consolidated financial reports 9

Income before tax (NT$Bn) Y2016 4.62-0.02 +0.29-0.01-0.55-0.10-0.45 +0.03 3.82-17.4% 2015 NII Fee Trading Others OP. Expense Provision Recovery 2016 1Q 2017 +0.19 1.03-0.13-0.004-0.16-0.002-0.12 +0.01 0.81-20.9% 1Q 2016 NII Fee Trading Others OP. Expense Provision Recovery 1Q 2017 Source: Consolidated financial reports 10

Profitability PPOP NIM & Spread (NT$Bn) 4.4 4.7-8.3% 4.3-11.5% (%) 1.75 1.76 1.71 1.64 0.9 0.8 1.25 1.26 1.29 1.14 2014 2015 2016 1Q 2016 1Q 2017 2014 2015 2016 1Q 2017 Spread of loan vs. deposit NIM ROA ROE (%) (%) 0.73 0.73 0.59 0.52* 11.33 10.43 8.12 7.08* 2014 2015 2016 1Q 2017 *annualized Source: Consolidated financial reports 2014 2015 2016 1Q 2017 11

Dividend EPS & dividend payout Cash dividend yield * (NT$/share) 1.30 1.31 1.30 1.04 3.8% 4.1% 4.4% 2.2% 0.45 0.54 0.20 0.23 0.25 0.40 0.40 0.42 2013 2014 2015 2016 2013 2014 2015 2016 Cash dividend Stock dividend * Based on stock closing price on BDR date proposing dividend distribution Source: Consolidated financial reports 12

Contents Financial highlights Key strategies 13

2017 key strategies Products Process Branding Assets Profit Relationship Consolidation Group synergy Payment platform Customer sharing 14

Contents Appendix 15

Summary financials and key ratios (NT$ m, except percentages and per share data) (Consolidated) As of or for 12 months ended December 31, As of or for 3 months ended March 31, 2015 (IFRS) 2016 (IFRS) 1Q2016 (IFRS) 1Q2017 (IFRS) Key balance sheet items Gross loans 338,597 360,995 7% 329,074 354,480 8% Total assets 546,555 561,415 3% 533,999 598,844 12% Deposits and remittances 451,295 452,720 0.3% 431,213 489,186 13% Total shareholders equity 38,978 40,951 5% 39,865 41,750 5% BVPS 12.85 13.16 2% 13.14 13.42 2% Key income statement items Net interest income 5,804 5,784-0.3% 1,476 1,344-9% Net fee income 3,104 3,392 9% 768 764-0.5% Earnings before Provision 4,652 4,268-8% 933 826-11% Net income 3,914 3,244-17% 862 732-15% EPS 1.30 1.04-20% 0.28 0.24-14% Key ratios Cost to income ratio 58.2% 61.0% 2.4 PctP 63.4% 66.3% 2.9 PctP ROE (not annualized) 10.43% 8.12% -2.3 PctP 2.19% 1.77% -42 bp ROA (not annualized) 0.73% 0.59% -14 bp 0.16% 0.13% -3 bp LDR 74.9% 79.6% 4.7 PctP 76.2% 72.6% -3.6 PctP NPL ratio 0.25% 0.19% -6 bp 0.27% 0.25% -2 bp Coverage ratio 531% 726% 195 PctP 501% 556% 55 PctP Tier 1 ratio (unconsolidated) 9.32% 9.52% 20 bp 9.82% 10.0% 18 bp Total CAR (unconsolidated) 12.64% 13.14% 50 bp 13.24% 13.79% 55 bp 16